000 02876nam a22003737a 4500
008 220511s20222022 xxu||||| |||| 00| 0 eng d
022 _a0090-4295
024 _a10.1016/j.urology.2022.02.027 [doi]
024 _aS0090-4295(22)00284-9 [pii]
040 _aOvid MEDLINE(R)
099 _a35427674
245 _aPropensity-Score Matched Analysis Between Extraperitoneal Single Port and Intraperitoneal Multiport Radical Prostatectomy: A Single-Institutional Experience.
251 _aUrology. 2022 Apr 12
252 _aUrology. 2022 Apr 12
253 _aUrology
260 _c2022
260 _fFY2022
260 _p2022 Apr 12
265 _saheadofprint
266 _d2022-05-11
520 _aCONCLUSIONS: The single port robotic system is a safe option for localized prostate cancer treatment, offering superior pain control and comparable perioperative results and intermediate-term functional outcomes compared to the multiport robotic approach. Copyright © 2022. Published by Elsevier Inc.
520 _aMATERIALS AND METHODS: We evaluated all patients who underwent robotic prostatectomy by three urologic surgeons at our institution between January 2019 and October 2020. Demographic, intraoperative, and postoperative data were collected and assessed. Patients were matched based on body mass index, Gleason group, and prostate volume using the optimal matching method.
520 _aOBJECTIVES: To compare the perioperative results and intermediate-term functional outcomes of single port and multiport robotic-assisted laparoscopic prostatectomy by using a propensity-score analysis.
520 _aRESULTS: Overall, 98 and 165 patients underwent single port and multiport robotic prostatectomy, respectively. Following propensity-score matching, 98 multiport cases were matched 1:1 to single port cases. The median operative time was lower for multiport (111.5 vs 147.0 minutes, p=0.0000). Single port had a lower median estimated blood loss (50.0 vs 75.0 mL, p=0.0006), pain score on postoperative day 0 (1.0 vs 2.0, p=0.0004), opioid use at postoperative day 1 (0.0 [IQR 0.0-5.0] vs 0.0 MME [IQR 0.0-7.5], p=0.0058), cumulative opioid use (2.0 vs 7.0 MME, p=0.0008), and lymph node yield (4.0 vs 7.0 nodes, p=0.0051). Single port had a greater percentage of men regain full erectile function by 6 months (23.8% vs 4.8%, p=0.002).
546 _aEnglish
650 _aIN PROCESS -- NOT YET INDEXED
656 _aMedStar Georgetown University Hospital/MedStar Washington Hospital Center
656 _aUrology Residency-Categorical
657 _aJournal Article
700 _aLulla, Tina
790 _aAhmed M, Billah M, Harrison R, Koster H, Lovallo G, Lulla T, Rosa RS, Stifelman M, Zaifman J
856 _uhttps://dx.doi.org/10.1016/j.urology.2022.02.027
_zhttps://dx.doi.org/10.1016/j.urology.2022.02.027
942 _cART
_dArticle
999 _c568
_d568